Paper334249
Enzymic and nonenzymic translocation by yeast polysomes. Site of action of a number of inhibitors.
Jiménez A and 2 others. Biochemistry, 1977. Cited by 61 papers, by iCite.
Cite this record
ConductScience Library. Enzymic and nonenzymic translocation by yeast polysomes. Site of action of a number of inhibitors. Papers, record 334249. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/334249
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Enzymic and nonenzymic translocation by yeast polysomes. Site of action of a number of inhibitors.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Polyribosomes | Major topic |
| Protein Biosynthesis | Major topic |
| Saccharomyces cerevisiae | Major topic |
| Animals | |
| Anti-Bacterial Agents | |
| Cycloheximide | |
| Emetine | |
| Ethylmaleimide | |
| Fusidic Acid | |
| Kinetics | |
| Mutation | |
| Potassium | |
| Puromycin | |
| Pyrans | |
| RNA, Transfer | |
| Rabbits | |
| Reticulocytes | |
| Ribosomes | |
| Species Specificity |
Source PubMed
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 61 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42477325 | Viral syncytia evolve to resist interferon. | Nat Commun | 2026 | https://conductscience.org/library/papers/42477325 | PubMed |
| 41269562 | A Versatile Ribo-seq Workflow for Enhanced Analysis of Ribosome Dynamics. | Methods Mol Biol | 2026 | https://conductscience.org/library/papers/41269562 | PubMed |
| 41121194 | Establishment of an imaging-based screening pipeline for the identification of human ribosome biogenesis inhibitors. | BMC Biol | 2025 | https://conductscience.org/library/papers/41121194 | PubMed |
| 36139404 | Emetine in Combination with Chloroquine Induces Oncolytic Potential of HIV-1-Based Lentiviral Particles. | Cells | 2022 | https://conductscience.org/library/papers/36139404 | PubMed |
| 35184897 | Spatiotemporally resolved protein synthesis as a molecular framework for memory consolidation. | Trends Neurosci | 2022 | https://conductscience.org/library/papers/35184897 | PubMed |
| 35164173 | Potential Antiviral Action of Alkaloids. | Molecules | 2022 | https://conductscience.org/library/papers/35164173 | PubMed |
| 34342579 | Selective dephosphorylation by PP2A-B55 directs the meiosis I-meiosis II transition in oocytes. | Elife | 2021 | https://conductscience.org/library/papers/34342579 | PubMed |
| 33711336 | Emetine suppresses SARS-CoV-2 replication by inhibiting interaction of viral mRNA with eIF4E. | Antiviral Res | 2021 | https://conductscience.org/library/papers/33711336 | PubMed |
| 33277927 | Drug repurposing approach to combating coronavirus: Potential drugs and drug targets. | Med Res Rev | 2021 | https://conductscience.org/library/papers/33277927 | PubMed |
| 33261173 | Emetine Is Not Ipecac: Considerations for Its Use as Treatment for SARS-CoV2. | Pharmaceuticals (Basel) | 2020 | https://conductscience.org/library/papers/33261173 | PubMed |
| 32844746 | Elongation inhibitors do not prevent the release of puromycylated nascent polypeptide chains from ribosomes. | Elife | 2020 | https://conductscience.org/library/papers/32844746 | PubMed |
| 32737302 | Signatures of co-deregulated genes and their transcriptional regulators in colorectal cancer. | NPJ Syst Biol Appl | 2020 | https://conductscience.org/library/papers/32737302 | PubMed |
| 32729169 | Biologically active isoquinoline alkaloids covering 2014-2018. | Med Res Rev | 2020 | https://conductscience.org/library/papers/32729169 | PubMed |
| 30293783 | ZNF598 Is a Quality Control Sensor of Collided Ribosomes. | Mol Cell | 2018 | https://conductscience.org/library/papers/30293783 | PubMed |
| 30133543 | A seven-helix protein constitutes stress granules crucial for regulating translation during human-to-mosquito transmission of Plasmodium falciparum. | PLoS Pathog | 2018 | https://conductscience.org/library/papers/30133543 | PubMed |
| 29872540 | Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry. | Cell Discov | 2018 | https://conductscience.org/library/papers/29872540 | PubMed |
| 29708497 | Co-translational protein targeting facilitates centrosomal recruitment of PCNT during centrosome maturation in vertebrates. | Elife | 2018 | https://conductscience.org/library/papers/29708497 | PubMed |
| 29565554 | A Complementary Chemical and Genomic Screening Approach for Druggable Targets in the Nrf2 Pathway and Small Molecule Inhibitors to Overcome Cancer Cell Drug Resistance. | ACS Chem Biol | 2018 | https://conductscience.org/library/papers/29565554 | PubMed |
| 29552591 | The RiboPuromycylation Method (RPM): an Immunofluorescence Technique to Map Translation Sites at the Sub-cellular Level. | Bio Protoc | 2018 | https://conductscience.org/library/papers/29552591 | PubMed |
| 29153549 | Anticancer activities of emetine prodrugs that are proteolytically activated by the prostate specific antigen (PSA) and evaluation of in vivo toxicity of emetine derivatives. | Bioorg Med Chem | 2017 | https://conductscience.org/library/papers/29153549 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/334249
GET https://conductscience.org/api/papers/v1/334249/cited_by?page=2